Evaluating the cytotoxic doses of narrowband and broadband UVB in human keratinocytes, melanocytes, and fibroblasts.
BACKGROUND
No comparative and simultaneous in vitro studies have been performed to determine the cytotoxic dose of narrowband UVB (NBUVB) and broadband UVB (BBUVB) for keratinocytes, melanocytes, and fibroblasts. Culture medium was often replaced with phosphate-buffered saline (PBS) before UV irradiation; however, its amount differed across studies. We determined the cytotoxic doses of NBUVB and BBUVB and tested for changes in viability according to the amount of PBS.


METHODS
We exposed cultured human keratinocytes, melanocytes, and fibroblasts to ultraviolet light in the range 12.5-1000 mJ/cm(2) for NBUVB and 1.25-100 mJ/cm(2) for BBUVB. The viability was assessed after 24 h. We also determined changes in viability at cytotoxic doses according to the amount of PBS (40, 80, and 120 microl/well in a 96-well plate).


RESULTS
Cytotoxicity was observed at doses of 100, 200, and 400 mJ/cm(2) for NBUVB and 5, 10, and 25 mJ/cm(2) for BBUVB in keratinocytes, melanocytes, and fibroblasts, respectively. At cytotoxic doses, there was no change in viability according to the amount of PBS.


CONCLUSIONS
Fibroblasts are more resistant to UVB irradiation, irrespective of the amount of NBUVB and BBUVB, than keratinocytes and melanocytes. The amount of PBS during irradiation had no effect on viability.
Cho
Tae-Ho
TH
Department of Dermatology, College of Medicine, Kyunghee University, Seoul, Korea.
Lee
Jin-Woo
JW
Lee
Mu-Hyoung
MH
D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D002478:Cells, Cultured; D004307:Dose-Response Relationship, Radiation; D005347:Fibroblasts / Q000502:physiology / Q000528:radiation effects*; D006801:Humans; D015603:Keratinocytes / Q000502:physiology / Q000528:radiation effects*; D008544:Melanocytes / Q000502:physiology / Q000528:radiation effects*; D010710:Phosphates / Q000494:pharmacology; D011829:Radiation Dosage; D011836:Radiation Tolerance; D012965:Sodium Chloride / Q000494:pharmacology; D014466:Ultraviolet Rays / Q000009:adverse effects*
D010710:Phosphates; D012965:Sodium Chloride